Parvus Therapeutics, Inc.

This was the first study in humans for an experimental drug called PVT201. The main goal was to check its initial safety and see how the body processes it. Researchers gave single, increasing doses to 24 healthy volunteers and a small group of patients with primary biliary cholan…